Development of a Machine Learning-Based Diagnostic Tool for Enzyme Activity Analysis

Thesis Abstract

Enzyme activity analysis plays a crucial role in clinical diagnostics, biochemical research, and pharmaceutical development; however, current methods are often constrained by time-consuming laboratory procedures, limited sensitivity, and the requirement for specialized expertise. The advent of machine learning (ML) offers a transformative potential to streamline enzyme activity detection through predictive modeling based on spectroscopic and enzymatic assay data. This study aims to develop an accurate and robust ML-based diagnostic tool that enhances the speed, sensitivity, and reliability of enzyme activity analysis. The specific objectives are to (1) compile and preprocess a comprehensive dataset comprising spectroscopic data and enzyme activity measurements, (2) compare the performance of multiple ML algorithms—including Random Forest, Support Vector Machine, and Neural Networks—in predicting enzyme activity levels, (3) evaluate the diagnostic accuracy and predictive robustness of the optimal model, and (4) implement a user-friendly software prototype integrating the best-performing model for practical deployment. The methodology employs a quantitative research design utilizing a cross-sectional approach. The study population includes enzyme samples sourced from 150 clinical and environmental laboratories, resulting in a dataset of approximately 1,200 enzyme activity readings. Stratified random sampling ensures diversity across enzyme types, temperature conditions, substrate concentrations, and sample origins. Data collection involves spectrophotometric assays capturing absorbance at specific wavelengths relevant to target enzymes, complemented by metadata such as pH, temperature, and incubation times. The integrity and validity of the dataset are maintained through calibration controls and duplicate measurements. Data preprocessing includes normalization, feature extraction, and dimensionality reduction using Principal Component Analysis (PCA). Model training and validation utilize 80% of the data, with the remaining 20% reserved for testing. The primary data analysis techniques encompass supervised ML algorithms—specifically Random Forests, Support Vector Machines, and Convolutional Neural Networks—implemented via Python’s Scikit-learn and TensorFlow libraries. Model performance is evaluated based on metrics such as accuracy, precision, recall, F1-score, and Receiver Operating Characteristic (ROC) curve analysis. Hyperparameter optimization is performed through grid search and cross-validation (k=10). To interpret model outputs and elucidate feature importance, techniques including SHAP (SHapley Additive exPlanations) are employed. The expected findings suggest that the neural network-based model will outperform traditional algorithms, achieving an accuracy exceeding 92% in enzyme activity prediction and demonstrating consistent robustness across enzyme types and assay conditions. The developed diagnostic tool is anticipated to significantly reduce analysis time—by up to 50%—and improve sensitivity, enabling early detection of enzyme deficiencies or activity variations with clinical relevance. This research contributes to the scientific community by offering an innovative, scalable framework for enzyme activity analysis, promoting integration of ICT-driven solutions into biochemical diagnostics. It builds upon established theories in machine learning and biochemical spectroscopy, notably leveraging the Theory of Digital Signal Processing and the Data-Driven Paradigm in Biological Systems. The development of an autonomous software prototype will facilitate adoption in clinical, industrial, and research settings, bridging gaps between computational intelligence and laboratory techniques. Policy implications include enhancing diagnostic accuracy, streamlining workflows, and reducing costs associated with enzyme assays. In conclusion, this study underscores the potential of machine learning to revolutionize enzyme activity analysis through accurate, rapid, and interpretable predictive models. Recommendations include further validation with larger datasets, integration with laboratory information management systems (LIMS), and exploration of real-time implementation. Future research avenues involve extending the model to cover a broader spectrum of enzymes and incorporating multi-omics data to enrich predictive capabilities. This work paves the way for smarter biochemical diagnostics, ultimately contributing to improved health outcomes and scientific understanding of enzymatic processes.